Clinical Trial Update: Rituximab in Rheumatoid Arthritis Lung Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated rituximab for rheumatoid arthritis with interstitial pneumonia. The study is completed and results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Pneumonia
• Rheumatoid Arthritis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Eric Matteson | Conditions: Rheumatoid Arthritis, Interstitial Pneumonia | Phase 3 | Status: COMPLETED | Results posted: 2012-09-25